Engagement · ENG-2026-09-2241

Advisory Board Engagement

Dr. Maria Schmidt

OncologistUniversity Hospital Munich

Date

2026-09-15

Duration

4 hours

Honorarium

€1,800

Sponsor

Helix Therapeutics Oncology Division

APPROVED with WARN

Evaluated 2026-05-30 16:42:11 UTC
Decision ID: DEC-2026-1847

Decision trace

5 rules evaluated · 1 warning

Full reasoning

EFPIA Germany aggregate annual disclosure threshold per HCP stands at €15,000. Dr. Schmidt's YTD aggregate is €4,200. With this engagement at €1,800, projected total is €6,000 (40% of threshold). No immediate disclosure action required, but flagged for Q4 monitoring per Helix SOP §4.2(c).

AI narrative

Generated by Lokatial AI· lokatial-policy-v4.2· 16:42 UTC

This €1,800 honorarium payment to Dr. Maria Schmidt (Oncologist, University Hospital Munich) for an Advisory Board engagement was approved on 2026-09-15. The payment is within all applicable regulatory limits - EFPIA Germany's oncology specialist cap of €2,100/hour is not exceeded, and Helix Therapeutics' internal cap of €2,000 is respected. One advisory flag: Dr. Schmidt's year-to-date aggregate spend will reach €6,000 with this payment, currently at 40% of the EFPIA Germany annual disclosure threshold of €15,000. No immediate action required, but monitor for Q4 engagements. Disclosure will be auto-included in next quarterly EFPIA Germany filing.

prompt: engagement.evaluate@2026.05 · reviewer: auto-approved · provenance hash: a7e4…91bc

Disclosure projection

YTD aggregate€4,200

After this engagement€6,000

EFPIA-DE threshold€15,000

40% of disclosure thresholdEFPIA-DE Q4 2026